FDA
-
-
-
-
-
-
-
Asgard Therapeutics names Wolfram Brugger as chief medical officer
-
-
-
-
-
-
-
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026
-
-
-
-
-
-
-
NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹
-
-
-
-
-
-
-
European Commission Approves CAR-T Therapy With Lentiviral Vectors Manufactured by AGC Biologics
-
-
-
-
-
-
-
Autolus Therapeutics to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
-
-
-
-
-
-
-
Agilent Technologies (A) xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
-
328,355 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

